Latest: FDA Approves New Biosimilar for Oncology Treatment
Oncology

DecisionDx-SCC Predicts Recurrence, Guides Imaging in Squamous Cell Carcinoma

by Cancer Network
0 Comments
0 Mins
Two studies were recently published that validated the use of the DecisionDx-SCC test as a tool for the treatment of cutaneous squamous cell carcinoma.
Tags:
Cancer Network
Author

Cancer Network

Previous Post
How is United Imaging Healthcare impacting medicine with its advanced scanners and imaging systems?
Next Post
Tirzepatide leads to greater weight loss than semaglutide among adults with obesity
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago